SKYE
Skye Bioscience·NASDAQ
--
--(--)
--
--(--)
3.82 / 10
Netural
The fund flow profile scores 7.64/10, demonstrating robust fund flow characteristics. Favorable Small and Extra-large movements are tempered by challenging overall, block, Medium, and Large dynamics, supporting positive flow assessment. Analyst consensus points to overwhelmingly bullish analyst consensus with strong conviction. Distribution analysis: Strong Buy(100.0%) among 1 research opinions, supported by 0.00 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-09-30
InstitutionHC Wainwright & Co.
Times predicted1
Historical Win Rate0.0%
What is the analyst consensus for SKYE?
- SKYE holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.82/10 (Netural).
